Authors

Kate Douglass, MS, RN, QP503A qualified

Vice President and Chief Development Officer
CriticalPoint, LLC
Kate Douglass, MS, RN, QP503A qualified, is chief development officer of CriticalPoint, LLC. She co-authored a paper commissioned by the Pew Charitable Trust titled “Quality Standards for Large-Scale Sterile Compounding Facilities” and is the senior member of the Sterile Compounding Boot Camp Live and Virtual Training Series faculty. Kate has personally supervised the design, engineering, and build of pharmacy compounding facilities that met or exceeded USP requirements, including the design and build of CriticalPoint’s Center for Training and Research in Totowa, New Jersey.

Recent Popular Articles

December 2021 : USP 800
December 2021 : USP 800
December 2021 : USP 800
December 2021 : USP 800

Current Issue